BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 15 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 15 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 15 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 17 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 17 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 17 hours ago Atmus Welcomes Heath Sharp to Board of Directors 19 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 19 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 15 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 15 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 15 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 17 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 17 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 17 hours ago Atmus Welcomes Heath Sharp to Board of Directors 19 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 19 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
AlphaGraphs

YY’s revenue surges 67% in Q2

Chinese social media company YY Inc (NASDAQ: YY) reported a revenue increase of 67% to RMB6.295 billion (US$917.0 million) from RMB3,773.2 million in the corresponding…

Market News

Bio-Path likely to report wider Q2 loss on Aug. 15

Bio-Path Holdings (NASDAQ: BPTH) is expected to continue incurring significant operating losses in the second quarter. Also, the losses are likely to increase substantially as…

Market News

CorMedix narrows loss in Q2, revenue miss estimates

CorMedix (NYSE: CRMD) reported mixed second quarter results after the bell. Revenue failed to beat estimates, while earnings came in better-than-expected. Last month, the biopharma…